Functional impact of human genetic variants of COL18A1/endostatin on pulmonary endothelium

Alice M. Goyanes, Aigul Moldobaeva, Mery Marimoutou, Lidenys C. Varela, Lan Wang, Laura F. Johnston, Meena M. Aladdin, Grace L. Peloquin, Bo S. Kim, Mahendra Damarla, Karthik Suresh, Takahiro Sato, Todd M. Kolb, Paul M. Hassoun, Rachel L. Damico

Research output: Contribution to journalArticlepeer-review


Pulmonary arterial hypertension (PAH) is an incurable disease characterized by disordered and dysfunctional angiogenesis leading to small-vessel loss and an obliterative vasculopathy. The pathogenesis of PAHis not fully understood, butmultiple studies have demonstrated links between elevated angiostatic factors, disease severity, and adverse clinical outcomes. ES (endostatin), one such circulating angiostatic peptide, is the cleavage product of the proteoglycan COL18A1 (collagen a1[XVIII] chain). Elevated serum ES is associated with increased mortality and disease severity in PAH. A nonsynonymous variant of ES (aspartic acid-to-asparagine substitution at amino acid 104; p.D104N) is associated with differences in PAH survival. Although COL18A1/ES expression is markedly increased in remodeled pulmonary vessels in PAH, the impact of ES on pulmonary endothelial cell (PEC) biology and molecular contributions to PAH severity remain undetermined. In the present study, we characterized the effects of exogenous ES on human PEC biology and signaling. We demonstrated that ES inhibits PEC migration, proliferation, and cell survival, with significant differences between human variants, indicating that they are functional genetic variants. ES promotes proteasomemediated degradation of the transcriptional repressor ID1, increasing expression and release of TSP-1 (thrombospondin 1). ES inhibits PEC migration via an ID1/TSP-1/CD36-dependent pathway, in contrast to proliferation and apoptosis, which require both CD36 and CD47. Collectively, the data implicate ES as a novel negative regulator of ID1 and an upstream propagator of an angiostatic signal cascade converging on CD36 and CD47, providing insight into the cellular and molecular effects of a functional genetic variant linked to altered outcomes in PAH.

Original languageEnglish (US)
Pages (from-to)524-534
Number of pages11
JournalAmerican journal of respiratory cell and molecular biology
Issue number4
StatePublished - 2020


  • Apoptosis
  • Endostatin
  • Migration
  • Proliferation
  • Pulmonary arterial hypertension

ASJC Scopus subject areas

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Clinical Biochemistry
  • Cell Biology

Fingerprint Dive into the research topics of 'Functional impact of human genetic variants of COL18A1/endostatin on pulmonary endothelium'. Together they form a unique fingerprint.

Cite this